oxybutynin has been researched along with triamcinolone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Jawade, KK; Taneja, R | 1 |
Galer, BS; Gammaitoni, AR; Jensen, MP; Radnovich, R; Trudeau, JJ | 1 |
2 trial(s) available for oxybutynin and triamcinolone
Article | Year |
---|---|
A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Benzhydryl Compounds; Cresols; Cystitis, Interstitial; Drug Therapy, Combination; Female; Heparin; Humans; Hydrocortisone; Injections, Intramuscular; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Triamcinolone | 2007 |
The pain quality response profile of a corticosteroid injections and heated lidocaine/tetracaine patch in the treatment of shoulder impingement syndrome.
Topics: Adult; Analysis of Variance; Anesthetics, Local; Anti-Inflammatory Agents; Female; Follow-Up Studies; Hot Temperature; Humans; Lidocaine; Male; Middle Aged; Pain Measurement; Shoulder Impingement Syndrome; Tetracaine; Time Factors; Transdermal Patch; Treatment Outcome; Triamcinolone | 2015 |
1 other study(ies) available for oxybutynin and triamcinolone
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |